study	name	time	time_end	time_unit	route	application	measurement_type	form	substance	value	unit	comments
Aboualfa2006	SOF400	S-28T1R28	NA	day	oral	multiple dose	dosing	NR	sorafenib	400	mg	"Patients received sorafenib 400 mg bid, but were allowed up to two dose reductions (200 mg bid and 200 mg qd) for drug-related toxicities (National Cancer Institute [Bethesda, MD] Common Toxicity Criteria v2.0). Otherwise, treatment continued until disease progression (PD) or unacceptable drug- related toxicities.
PK was assessed in 22 patients on or after 28 days of dosing."
